Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: J Am Geriatr Soc. 2021 Jan 7;69(4):979–985. doi: 10.1111/jgs.16975

Table 2.

Predictors of moderate and high-intensity statin prescription

OR Lower 95%CI Upper 95%CI P value
Female (ref = Male) 0.77 0.74 0.80 <0.001
Race (ref = NHW)
 Black 0.96 0.82 1.13 0.654
 Asian 1.20 1.14 1.26 <0.001
 Hispanic 0.94 0.87 1.02 0.127
 Other 0.94 0.83 1.07 0.360
ASCVD (ref = CAD)
 CVD 1.38 1.30 1.47 <0.001
 PAD 1.14 1.05 1.25 0.002
 Polyvascular 1.27 1.16 1.39 <0.001
Comorbidities
 Hypertension 1.36 1.31 1.42 <0.001
 Diabetes 1.59 1.52 1.66 <0.001
 Heart Failure 0.69 0.65 0.74 <0.001
 Cancer 1.00 0.96 1.04 0.916
 Renal disease 1.02 0.97 1.06 0.486
 Dementia 0.88 0.82 0.95 0.001
 Polypharmacy 1.28 1.23 1.33 <0.001
BMI (ref = normal BMI)
 Underweight 0.64 0.57 0.73 <0.001
 Overweight 1.35 1.30 1.41 <0.001
 Obese 1.49 1.41 1.57 <0.001
 Current smoker 1.25 1.10 1.42 0.001

Abbreviations and definitions: OR, odds ratio; ref, reference; NHW, non-Hispanic white; ASCVD, atherosclerotic cardiovascular disease; CAD, coronary artery disease; CVD, cerebrovascular disease, PAD, peripheral artery disease; polyvascular, 2 or more types of atherosclerotic cardiovascular disease; polypharmacy, >9 prescription medications; BMI, body mass index. Odds ratios adjusted for all other covariates presented as well as being in the top 5 percentile of number of office visits in the preceding year.